HomeNewsTrendsHealthMumbai sees a dip in COVID cases; 13,702 infected and 6 deaths

Mumbai sees a dip in COVID cases; 13,702 infected and 6 deaths

The dip comes in a day after the city reported 16,420 new positive cases on January 12 which was around 41 per cent more than the previous day, the Brihanmumbai Municipal Corporation (BMC) had said.

January 13, 2022 / 20:15 IST
Story continues below Advertisement
Representative image.
Representative image.

Mumbai on January 13 reported 13,702 new COVID-19 cases and six deaths in the last 24 hours.  With this, the active cases in the financial capital stands at 95,123.

The dip in cases comes a day after the city reported 16,420 new positive cases on January 12 which was around 41 per cent more than the previous day.

Story continues below Advertisement

The city had been witnessing a drop in daily cases after reporting the highest ever 20,971 cases on January 7. On Tuesday, it had reported 11,647 cases, while two patients had succumbed to the infection that day.

Meanwhile, Mumbai Mayor Kishori Pednekar also said the numbers of COVID-19 cases and its fast spreading variant Omircon were slowing coming down in the city, and appealed to citizens to get vaccinated against the viral infection.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show